Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 2.800
+0.140 (5.26%)
Mar 17, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €165.88 million as of March 17, 2026. Its market cap has increased by 196.89% in one year.
Market Cap
165.88M
Enterprise Value
183.95M
Revenue
5.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.80
Market Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 165.88M, an increase of 14.16%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 157.59M | 131.50% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | 145.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 227.54M |
| Median Technologies | 176.15M |
| Guerbet | 111.39M |
| Diagnostic Medical Systems | 32.89M |
| Implanet | 27.51M |
| Novacyt | 27.08M |
| Theraclion | 23.49M |
| Ikonisys | 23.29M |